These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16481907)

  • 1. Contrast-enhanced, high-resolution, susceptibility-weighted magnetic resonance imaging of the brain: dose-dependent optimization at 3 tesla and 1.5 tesla in healthy volunteers.
    Noebauer-Huhmann IM; Pinker K; Barth M; Mlynarik V; Ba-Ssalamah A; Saringer WF; Weber M; Benesch T; Witoszynskyj S; Rauscher A; Reichenbach JR; Trattnig S
    Invest Radiol; 2006 Mar; 41(3):249-55. PubMed ID: 16481907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose contrast-enhanced magnetic resonance imaging of brain metastases at 3.0 T using high-relaxivity contrast agents.
    Huang B; Liang CH; Liu HJ; Wang GY; Zhang SX
    Acta Radiol; 2010 Feb; 51(1):78-84. PubMed ID: 19912078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraindividual comparison of gadobenate dimeglumine and gadobutrol for cerebral magnetic resonance perfusion imaging at 1.5 T.
    Essig M; Lodemann KP; Le-Huu M; Brüning R; Kirchin M; Reith W
    Invest Radiol; 2006 Mar; 41(3):256-63. PubMed ID: 16481908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
    Manka C; Träber F; Gieseke J; Schild HH; Kuhl CK
    Radiology; 2005 Mar; 234(3):869-77. PubMed ID: 15665227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
    Bauner KU; Reiser MF; Huber AM
    Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of contrast agents with high molarity and with weak protein binding in cerebral perfusion imaging at 3 T.
    Thilmann O; Larsson EM; Björkman-Burtscher IM; Ståhlberg F; Wirestam R
    J Magn Reson Imaging; 2005 Nov; 22(5):597-604. PubMed ID: 16200539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging.
    Balci NC; Inan N; Anik Y; Erturk MS; Ural D; Demirci A
    Acad Radiol; 2006 Jul; 13(7):833-9. PubMed ID: 16777557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators.
    Essig M; Tartaro A; Tartaglione T; Pirovano G; Kirchin MA; Spinazzi A
    Acad Radiol; 2006 Jun; 13(6):744-51. PubMed ID: 16679277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-resolution three-dimensional contrast-enhanced blood oxygenation level-dependent magnetic resonance venography of brain tumors at 3 Tesla: first clinical experience and comparison with 1.5 Tesla.
    Barth M; Nöbauer-Huhmann IM; Reichenbach JR; Mlynárik V; Schöggl A; Matula C; Trattnig S
    Invest Radiol; 2003 Jul; 38(7):409-14. PubMed ID: 12821854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain tumor enhancement in magnetic resonance imaging: dependency on the level of protein binding of applied contrast agents.
    Wintersperger BJ; Runge VM; Tweedle MF; Jackson CB; Reiser MF
    Invest Radiol; 2009 Feb; 44(2):89-94. PubMed ID: 19077910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging: comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model.
    Runge VM; Biswas J; Wintersperger BJ; Baumann SS; Jackson CB; Herborn CU; Patel T
    Invest Radiol; 2006 Mar; 41(3):244-8. PubMed ID: 16481906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3.0 Tesla high spatial resolution contrast-enhanced magnetic resonance angiography (CE-MRA) of the pulmonary circulation: initial experience with a 32-channel phased array coil using a high relaxivity contrast agent.
    Nael K; Fenchel M; Krishnam M; Finn JP; Laub G; Ruehm SG
    Invest Radiol; 2007 Jun; 42(6):392-8. PubMed ID: 17507810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-individual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for contrast-enhanced magnetic resonance angiography of the supraaortic vessels at 3 Tesla.
    Bueltmann E; Erb G; Kirchin MA; Klose U; Naegele T
    Invest Radiol; 2008 Oct; 43(10):695-702. PubMed ID: 18791411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of contrast dose and field strength in the magnetic resonance detection of brain metastases.
    Ba-Ssalamah A; Nöbauer-Huhmann IM; Pinker K; Schibany N; Prokesch R; Mehrain S; Mlynárik V; Fog A; Heimberger K; Trattnig S
    Invest Radiol; 2003 Jul; 38(7):415-22. PubMed ID: 12821855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose comparison of single- vs. double-dose in contrast-enhanced magnetic resonance angiography of the carotid arteries: Intraindividual cross-over blinded trial using Gd-DTPA.
    Jourdan C; Heverhagen JT; Knopp MV
    J Magn Reson Imaging; 2007 Mar; 25(3):557-63. PubMed ID: 17326082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
    Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraindividual comparison between gadopentetate dimeglumine and gadobutrol for magnetic resonance perfusion in normal brain and intracranial tumors at 3 Tesla.
    Giesel FL; Mehndiratta A; Risse F; Rius M; Zechmann CM; von Tengg-Kobligk H; Gerigk L; Kauczor HU; Politi M; Essig M; Griffiths PD; Wilkinson ID
    Acta Radiol; 2009 Jun; 50(5):521-30. PubMed ID: 19337867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal liver lesions: whether a standard dose (0.05 mmol/kg) gadobenate dimeglumine can provide the same diagnostic data as the 0.1 mmol/kg dose.
    Nural MS; Gokce E; Danaci M; Bayrak IK; Diren HB
    Eur J Radiol; 2008 Apr; 66(1):65-74. PubMed ID: 17555901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraindividual comparison of image quality in MR urography at 1.5 and 3 tesla in an animal model.
    Regier M; Nolte-Ernsting C; Adam G; Kemper J
    Rofo; 2008 Oct; 180(10):915-21. PubMed ID: 19238642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo biochemical 7.0 Tesla magnetic resonance: preliminary results of dGEMRIC, zonal T2, and T2* mapping of articular cartilage.
    Welsch GH; Mamisch TC; Hughes T; Zilkens C; Quirbach S; Scheffler K; Kraff O; Schweitzer ME; Szomolanyi P; Trattnig S
    Invest Radiol; 2008 Sep; 43(9):619-26. PubMed ID: 18708855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.